CClinicalTrials.gg
SuspendedNCT06684496Updated Mar 12, 2026

A Study of High-intensity Strength Training and Thoracic Aorta Dilatation

An observational study in Thoracic Aorta Dilatation, sponsored by Mayo Clinic. Suspended at 1 site in United States. Open to participants aged 35 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by Mayo Clinic · Observational

Why this study was suspended
Pending additional funding
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
45
Ages
35 Years and older
Sex
All
01

Study summary

The purpose of this study is to describe the prevalence of thoracic aorta dilatation among a group of older (age > 35 years), experienced weightlifters (>5 years of weightlifting experience). The secondary aim of this study is to report the prevalence of thoracic aorta dilatation among 3 different groups of weightlifters (body builders, cross-fit athletes, and power lifters).

02

Conditions studied

  • Thoracic Aorta Dilatation
03

In context

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The target population is power lifters (n=15), body builders (n=15), and cross-fit (n=15) athletes age 35 years or older with at least 5 years of consistent weight training

Inclusion criteria

  • Age ≥ 35
  • ≥5 years of weightlifting experience

Exclusion criteria

Exclusion Criteria:

  • Age \< 35
  • \< 5 years of weightlifting experience
  • personal history of thoracic aorta dilatation/aneurysm/dissection
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
45 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Number of subjects with thoracic aorta dilatation

    Thoracic aorta dilatation will be measured by TTE (Transthoracic echocardiogram). A value over 40 mm indicates thoracic aorta dilatation.

    Time frame: Baseline

07

Study locations

1 site
  • Mayo Clinic
    Rochester, Minnesota 55905, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06684496
Lead sponsor
Mayo Clinic
Responsible party
Darrell B. Newman (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Nov 12, 2024
Start date
Dec 23, 2024
Primary completion
Nov 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Mar 12, 2026

Study contacts

Darrell Newman, M.D.
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is suspended, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion